Sinofn Health
Sinofn Health
Advanced formulations engineered for efficacy and market competitiveness.
The global dietary supplement market is undergoing a seismic shift from "general wellness" to "precision nutrition." As a leading OEM Health Supplements Manufacturer, SINOFN Health stays at the forefront of this evolution. We identify three critical macro trends currently shaping the industry:
Total Addressable Market Projection: $250B+ by 2028
Key Sector: Metabolic Health & Longevity
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences (CAS). Established in 2025 as the trading hub for global partners, we operate from Shanghai to bridge the gap between cutting-edge biotechnology and commercial consumer health products.
Our competitive edge lies in our origin: we don't just manufacture; we innovate. By leveraging our CAS partnership, we provide "Information Gain" to our clients—offering proprietary formulations and scientific validation that competitors cannot replicate.
During her clinical work, Mrs. Liu witnessed the lifelong struggles of PKU (Phenylketonuria) children, where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
"We measure success not just in revenue, but in lives improved through accessible science." – Mrs. GuoHong Liu
Under her leadership, SINOFN expanded from PKU specialized nutrition into FSMP, clinical nutrition, and a full suite of nutraceuticals, always maintaining a "Profit with Purpose" model.
Through cooperation with top universities and internal team building, SINOFN has established a world-class scientific research team.
Medical Innovation Director
Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations and clinical nutrition.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems and bioavailability enhancement.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist and expert in global nutraceutical delivery technologies.Driving the next generation of supplement efficacy through advanced biopharma-grade technology.
Implementation of liposomal encapsulation for Vitamin C and NMN to ensure maximum intestinal absorption and cellular uptake.
Using machine learning to predict synergistic effects between botanicals and synthetic compounds for personalized "Smart Supplements."
Expansion of plant-based prebiotic energy drinks and fermentation-derived bioactive compounds to reduce environmental footprint.
10+ dedicated lines (softgels, gummies, powders). ISO 22000, HACCP, FSSC 22000 certified. Annual capacity: 500M+ units.
HPLC/GC-MS contaminant screening, microbiological safety testing, and stability/dissolution validation.
Pilot-scale prototyping for tablets/capsules/liquids and bioavailability optimization studies.
Production Footprint
Capital (RMB)
Patents Held
Registered Trademarks
Navigating the complex regulatory landscape is the biggest hurdle for health brands. SINOFN provides comprehensive compliance support for major global markets:
FDA labeling compliance, DSHEA guidelines, and cGMP certification alignment.
EFSA health claim validation and EFSA-compliant ingredient sourcing.
HALAL certification and localized formulation adjustments for climatic stability.
Where SINOFN science meets consumer needs.
Our SHAPING MASTER™ series provides high-purity creatine and energy gels for professional athletes requiring rapid recovery and sustained output.
Specialized FSMP formulations for patients with PKU or other metabolic disorders, ensuring nutritional adequacy without metabolic stress.
NMN precursors and Tremella polysaccharides focused on cellular rejuvenation and skin-deep health from within.
SINOFN prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design). Certified with ISO9001, ISO22000, HACCP, and HALAL.
Unlike standard amino acid mixes, our PKU foods are developed using proprietary technology from the Chinese Academy of Sciences to mask the natural bitterness of amino acids, improving patient compliance and long-term health outcomes.
Yes. We have a dedicated pilot-scale R&D center that allows for rapid prototyping and stability testing for startups and new product launches before full-scale GMP production.
Each batch of our OEM NMN (≥99% purity) undergoes HPLC testing and third-party validation to ensure zero heavy metal contamination and consistent NAD+ precursor activity.
Absolutely. Our team, led by Dutch formulation expert Hans van Dijk, specializes in EU and US regulatory alignment, ensuring your product is ready for export from day one.
